TheProfitWatch

GNLX - Genelux Corporation Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.28 0.26 (4.92%) --- --- --- --- 0.17 (3.22%) 0.0 (0.0%) 0.0 (0.0%)

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.2
Diluted EPS:
-0.2
Basic P/E:
-27.7
Diluted P/E:
-27.7
RSI(14) 1m:
100.0
VWAP:
5.54
RVol:

Events

Period Kind Movement Occurred At

Related News